All Stories

  1. Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system

    Article • International Journal of Risk & Safety in Medicine, May 2023, IOS Press

    Dr Prasad S Nishtala

  2. Analysis of the nervous system and gastrointestinal adverse events associated with solifenacin in older adults using the US FDA adverse event reporting system

    Article • International Journal of Risk & Safety in Medicine, January 2023, IOS Press

    Dr Prasad S Nishtala

  3. ESTABLISHING GUIDELINES FOR ALTERNATIVES TO ANTICHOLINERGIC MEDICATIONS IN OLDER ADULTS WITH DEMENTIA

    Article • Alzheimer s & Dementia, July 2019, Elsevier

    Dr Prasad S Nishtala

  4. Reducing Potentially Inappropriate Medications in Older Adults: A Way Forward

    Article • Canadian Journal on Aging / La Revue canadienne du vieillissement, March 2019, Cambridge University Press

    Dr Prasad S Nishtala

  5. Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics

    Article • Cardiovascular Drugs and Therapy, March 2019, Springer Science + Business Media

    Dr Prasad S Nishtala

  6. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities

    Article • International Journal of Clinical Pharmacy, January 2019, Springer Science + Business Media

    Dr Prasad S Nishtala

  7. Factors associated with inappropriate prescribing among older adults with complex care needs who have undergone the interRAI assessment

    Article • Current Medical Research and Opinion, October 2018, Taylor & Francis

    Dr Prasad S Nishtala

  8. Determinants of prescribing potentially inappropriate medications in a nationwide cohort of community dwellers with dementia receiving a comprehensive geriatric assessment

    Article • International Journal of Geriatric Psychiatry, October 2018, Wiley

    Dr Prasad S Nishtala

  9. Pharmaceutical Care in Australia and New Zealand

    Article • September 2018, Springer Science + Business Media

    Dr Prasad S Nishtala

  10. The impact of residential medication management reviews (RMMRs) on medication regimen complexity

    Article • Postgraduate Medicine, August 2018, Taylor & Francis

    Dr Prasad S Nishtala

  11. Abstract

    Article • Pharmacoepidemiology and Drug Safety, August 2018, Wiley

    Amanj Kurdi, Dr Prasad S Nishtala

  12. Drug burden index and its association with hip fracture among older adults: a national population-based study

    Article • The Journals of Gerontology Series A, July 2018, Oxford University Press (OUP)

    Dr Prasad S Nishtala

  13. Association rules method and big data: Evaluating frequent medication combinations associated with fractures in older adults

    Article • Pharmacoepidemiology and Drug Safety, April 2018, Wiley

    Dr Prasad S Nishtala

  14. A systematic review evaluating the use of the interRAI home care instrument in research for older people

    Article • Clinical Gerontologist, March 2018, Taylor & Francis

    Dr Prasad S Nishtala

  15. Population-based study examining the utilization of preventive medicines by older people in the last year of life

    Article • Geriatrics and Gerontology International, February 2018, Wiley

    Dr Prasad S Nishtala

  16. Potentially inappropriate medications in community-dwelling older adults undertaken as a comprehensive geriatric risk assessment

    Article • European Journal of Clinical Pharmacology, January 2018, Springer Science + Business Media

    Dr Prasad S Nishtala

  17. Impact of medication reviews on inappropriate prescribing in aged care

    Article • Current Medical Research and Opinion, January 2018, Taylor & Francis

    Dr Prasad S Nishtala

  18. Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study

    Article • Drugs & Aging, December 2017, Springer Science + Business Media

    Dr Prasad S Nishtala

  19. A population-level study examining discontinuation of statins in older people with dementia

    Article • European Journal of Clinical Pharmacology, December 2017, Springer Science + Business Media

    Dr Prasad S Nishtala

  20. Do Residents Need All Their Medications? A Cross-Sectional Survey of RNs' Views on Deprescribing and the Role of Clinical Pharmacists

    Article • Journal of Gerontological Nursing, October 2017, SLACK, Inc.

    Dr Prasad S Nishtala

  21. Evaluation of the National Minimum Data Set for Neurological Conditions in Older Adults

    Article • Journal of Geriatric Psychiatry and Neurology, September 2017, SAGE Publications

    Dr Prasad S Nishtala

  22. Development and validation of a Medicines Comorbidity Index for older people

    Article • European Journal of Clinical Pharmacology, September 2017, Springer Science + Business Media

    Dr Prasad S Nishtala

  23. Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review

    Article • Drugs & Aging, August 2017, Springer Science + Business Media

    Dr Prasad S Nishtala

  24. International trends in antipsychotic use: A study in 16 countries, 2005–2014

    Article • European Neuropsychopharmacology, July 2017, Elsevier

    Dr Prasad S Nishtala

  25. CAN DEPRESCRIBING GIVE WHAT POLYPHARMACY HAS TAKEN AWAY? FEASIBILITY TRIAL IN RESIDENTIAL AGED CARE

    Article • June 2017, Oxford University Press (OUP)

    Dr Prasad S Nishtala

  26. DO MY PATIENTS NEED ALL THEIR MEDICINES? REGISTERED NURSES’ VIEWS ON DEPRESCRIBING

    Article • June 2017, Oxford University Press (OUP)

    Dr Prasad S Nishtala

  27. International trends in clozapine use: a study in 17 countries

    Article • Acta Psychiatrica Scandinavica, May 2017, Wiley

    Dr Prasad S Nishtala, Dr Jorge E Machado-Alba, Dr Sam Hollingworth

  28. Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities

    Article • BMJ Open, April 2017, BMJ

    Dr Prasad S Nishtala

  29. New Zealand's interRAI: A Resource For Examining Health Outcomes in Geriatric Pharmacoepidemiology

    Article • Journal of the American Geriatrics Society, February 2017, Wiley

    Dr Prasad S Nishtala

  30. Zopiclone Use and Risk of Fractures in Older People: Population-Based Study

    Article • Journal of the American Medical Directors Association, February 2017, Elsevier

    Dr Prasad S Nishtala

  31. GLUCOSE MONITORING IN NEW USERS OF SECOND-GENERATION ANTIPSYCHOTICS IN OLDER PEOPLE

    Article • Archives of Gerontology and Geriatrics, January 2017, Elsevier

    Dr Prasad S Nishtala

  32. Exploring New Zealand prescription data using sequence symmetry analyses for predicting adverse drug reactions

    Article • Journal of Clinical Pharmacy and Therapeutics, December 2016, Wiley

    Dr Prasad S Nishtala

  33. Decade-long temporal trends in the utilization of preventive medicines by centenarians

    Article • Journal of Clinical Pharmacy and Therapeutics, December 2016, Wiley

    Dr Prasad S Nishtala

  34. Adverse Drug Reactions Associated With Cholinesterase Inhibitors—Sequence Symmetry Analyses Using Prescription Claims Data

    Article • Journal of the American Medical Directors Association, December 2016, Elsevier

    Dr Prasad S Nishtala

  35. Real-world risk of diabetes with antipsychotic use in older New Zealanders: a case-crossover study

    Article • European Journal of Clinical Pharmacology, November 2016, Springer Science + Business Media

    Dr Prasad S Nishtala

  36. Cognitive adverse effects and brain deterioration associated with use of anticholinergic activity medicines in older adults

    Article • Evidence-Based Medicine, November 2016, BMJ

    Dr Prasad S Nishtala

  37. Time-to-First Discontinuation, Adherence and Persistence in New Users of Second-Generation Antipsychotics

    Article • Journal of Clinical Psychopharmacology, October 2016, Wolters Kluwer Health

    Dr Prasad S Nishtala

  38. A systematic review and meta-analysis on serum anticholinergic activity and adverse outcomes in older people

    Article • Research in Social and Administrative Pharmacy, September 2016, Elsevier

    Dr Prasad S Nishtala

  39. Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New Zealand

    Article • Therapeutic Advances in Drug Safety, July 2016, SAGE Publications

    Dr Prasad S Nishtala

  40. Antihypertensive medicines utilization: A decade-long nationwide study of octogenarians, nonagenarians and centenarians

    Article • Geriatrics and Gerontology International, July 2016, Wiley

    Dr Prasad S Nishtala

  41. An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice

    Article • Saudi Pharmaceutical Journal, July 2016, Elsevier

    Dr Prasad S Nishtala

  42. Temporal trends for donepezil utilization among older people

    Article • International Clinical Psychopharmacology, May 2016, Wolters Kluwer Health

    Dr Prasad S Nishtala

  43. Challenges and Enablers of Deprescribing: A General Practitioner Perspective

    Article • PLoS ONE, April 2016, PLOS

    Dr Prasad S Nishtala

  44. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk

    Article • Journal of Clinical Pharmacy and Therapeutics, April 2016, Wiley

    Dr Prasad S Nishtala

  45. Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research

    Article • Drugs & Aging, April 2016, Springer Science + Business Media

    Dr Prasad S Nishtala

  46. Discontinuation of statins in a population of older New Zealanders with limited life expectancy

    Article • Internal Medicine Journal, April 2016, Wiley

    Dr Prasad S Nishtala

  47. Antiepileptic medicine utilization in older people over a 9-year study period

    Article • Geriatric Mental Health Care, April 2016, Elsevier

    Dr Prasad S Nishtala

  48. Anticholinergics: theoretical and clinical overview

    Article • Expert Opinion on Drug Safety, March 2016, Informa Healthcare

    Dr Prasad S Nishtala

  49. Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature

    Article • PLoS ONE, March 2016, PLOS

    Dr Prasad S Nishtala

  50. Geographic variation in psychotropic drug utilisation among older people in New Zealand

    Article • Australasian Journal on Ageing, March 2016, Wiley

    Dr Prasad S Nishtala

  51. General practitioners’ insight into deprescribing for the multimorbid older individual: a qualitative study

    Article • International Journal of Clinical Practice, February 2016, Wiley

    Dr Prasad S Nishtala

  52. BMC Geriatrics reviewer acknowledgement 2015

    Article • BMC Geriatrics, February 2016, Springer Science + Business Media

    Dr Prasad S Nishtala

  53. Examining potentially inappropriate prescribing in residential care using the STOPP/START criteria

    Article • European Geriatric Medicine, February 2016, Elsevier

    Dr Prasad S Nishtala

  54. The Influence of Patient Characteristics on Anticholinergic Events in Older People

    Article • Dementia and Geriatric Cognitive Disorders Extra, January 2016, Karger Publishers

    Dr Prasad S Nishtala

  55. ‘Real-world’ haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand

    Article • International Journal of Cardiology, January 2016, Elsevier

    Dr Prasad S Nishtala

  56. Temporal trends in the utilisation of preventive medicines by older people: A 9-year population-based study

    Article • Archives of Gerontology and Geriatrics, January 2016, Elsevier

    Dr Prasad S Nishtala

  57. Quality use of antipsychotic medicines inresidential aged care facilities in New Zealand

    Article • Journal of Primary Health Care, January 2016, CSIRO Publishing

    Dr Prasad S Nishtala

  58. Donepezil Adherence, Persistence and Time to First Discontinuation in a Three-Year Follow-Up of Older People

    Article • Dementia and Geriatric Cognitive Disorders Extra, December 2015, Karger Publishers

    Dr Prasad S Nishtala

  59. Impact of residential medication management reviews on anticholinergic burden in aged care residents

    Article • Current Medical Research and Opinion, November 2015, Informa Healthcare

    Dr Prasad S Nishtala

  60. Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013

    Article • Internal Medicine Journal, June 2015, Wiley

    Dr Prasad S Nishtala

  61. Analgesic Medicine Utilization in Older People in New Zealand from 2005 to 2013

    Article • Drugs - Real World Outcomes, May 2015, Springer Science + Business Media

    Dr Prasad S Nishtala

  62. Credentials for a PharmD graduate: The voyage never ends

    Article • SAGE Open Medicine, May 2015, SAGE Publications

    Dr Prasad S Nishtala

  63. Prevalence of potentially inappropriate medicine use in older New Zealanders: a population-level study using the updated 2012 Beers criteria

    Article • Journal of Evaluation in Clinical Practice, May 2015, Wiley

    Dr Prasad S Nishtala

  64. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review

    Article • BMC Geriatrics, March 2015, Springer Science + Business Media

    Dr Prasad S Nishtala

  65. Associations of Potentially Inappropriate Medicine Use with Fall-Related Hospitalisations and Primary Care Visits in Older New Zealanders: A Population-Level Study Using the Updated 2012 Beers Criteria

    Article • Drugs - Real World Outcomes, March 2015, Springer Science + Business Media

    Dr Prasad S Nishtala

  66. Comparison of Anticholinergic Risk Scales and Associations with Adverse Health Outcomes in Older People

    Article • Journal of the American Geriatrics Society, January 2015, Wiley

    Dr Prasad S Nishtala

  67. Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005-2013

    Article • Gerontology, November 2014, Karger Publishers

    Dr Prasad S Nishtala

  68. Psychotropic Medicine Utilization in Older People in New Zealand from 2005 to 2013

    Article • Drugs & Aging, September 2014, Springer Science + Business Media

    Dr Prasad S Nishtala

  69. Impact of the Pharmacist Medication Review Services on Drug-Related Problems and Potentially Inappropriate Prescribing of Renally Cleared Medications in Residents of Aged Care Facilities

    Article • Drugs & Aging, September 2014, Springer Science + Business Media

    Dr Prasad S Nishtala

  70. The impact of focused teaching sessions on New Zealand pharmacy students’ attitudes to people suffering from schizophrenia and other mental illnesses

    Article • Research in Social and Administrative Pharmacy, September 2014, Elsevier

    Dr Prasad S Nishtala

  71. Associations of drug burden index with falls, general practitioner visits, and mortality in older people

    Article • Pharmacoepidemiology and Drug Safety, April 2014, Wiley

    Dr Prasad S Nishtala

  72. Impact of Anticholinergic Discontinuation on Cognitive Outcomes in Older People: A Systematic Review

    Article • Drugs & Aging, February 2014, Springer Science + Business Media

    Dr Prasad S Nishtala

  73. Older people's perceptions of prescription medicine costs and related costs: a pilot study in New Zealand

    Article • Journal of Primary Health Care, January 2014, CSIRO Publishing

    Dr Prasad S Nishtala

  74. Anticholinergic Component of the Drug Burden Index and the Anticholinergic Drug Scale as Measures of Anticholinergic Exposure in Older People in New Zealand: A Population-Level Study

    Article • Drugs & Aging, August 2013, Springer Science + Business Media

    Dr Prasad S Nishtala

  75. Potentially inappropriate medicines in a cohort of community-dwelling older people in New Zealand

    Article • Geriatrics and Gerontology International, March 2013, Wiley

    Dr Prasad S Nishtala

  76. A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners

    Article • Journal of Evaluation in Clinical Practice, September 2010, Wiley

    Dr Prasad S Nishtala

  77. Determinants of antipsychotic medication use among older people living in aged care homes in Australia

    Article • International Journal of Geriatric Psychiatry, May 2010, Wiley

    Dr Prasad S Nishtala

  78. Drug Burden Index and Potentially Inappropriate Medications in Community-Dwelling Older People

    Article • Drugs & Aging, February 2010, Springer Science + Business Media

    Dr Prasad S Nishtala

  79. Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People

    Article • The Journal of Clinical Pharmacology, October 2009, Wiley

    Dr Prasad S Nishtala

  80. Impact of Residential Medication Management Reviews on Drug Burden Index in Aged-Care Homes

    Article • Drugs & Aging, August 2009, Springer Science + Business Media

    Dr Prasad S Nishtala

  81. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: A retrospective study

    Article • The American Journal of Geriatric Pharmacotherapy, August 2009, Elsevier

    Dr Prasad S Nishtala

  82. Psychotropic Prescribing in Long-Term Care Facilities: Impact of Medication Reviews and Educational Interventions

    Article • American Journal of Geriatric Psychiatry, August 2008, Elsevier

    Dr Prasad S Nishtala

  83. Response to Dr. Prasad

    Article • Medical Care, March 1981, Wolters Kluwer Health

    Dr Prasad S Nishtala